Skip to content

CareDx CDNA Prepaid & Other Current

Prepaid & Other Current at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$9M-47.1%
AAR Corp logo
AAR CorpAIR
$1M-84.1%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$2.49M+378%
REX American Resources logo
REX American ResourcesREX
$1.8M+2,713%
CareDx logo
CareDxCDNA
$2.88M+3.6%
Enliven Therapeutics logo
Enliven TherapeuticsELVN
-$1.65M-1,184%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's prepaid & other current?
CareDx (CDNA) reported prepaid & other current of $2.88M in Q1 2026.
How has CareDx's prepaid & other current changed year-over-year?
CareDx's prepaid & other current increased by 3.6% year-over-year, from $2.78M to $2.88M.
What does prepaid & other current mean?
Measures the net change in cash outflows for expenses paid in advance, such as insurance, software licenses, or service contracts. An increase in this balance indicates a use of cash, while a decrease represents the consumption of previously paid assets, impacting short-term liquidity.